Precigen (PGEN) Tax Provisions (2014 - 2025)
Precigen's (PGEN) quarterly Tax Provisions came in at $3000.0 in Q2 2025, up 100.18% year-on-year from $1498.7 in Q2 2024, and up 103.45% on a QoQ basis from -$87000.0 in Q4 2024.
Precigen (PGEN) Tax Provisions (2014 - 2025) Analysis & Trends
Precigen (PGEN) has 12 years of Tax Provisions data on file, last reported at $3000.0 in Q2 2025.
- On a quarterly basis, Tax Provisions rose 100.18% year-over-year to $3000.0 in Q2 2025; TTM through Mar 2026 was $3000.0, a 100.17% increase from a year earlier, with the FY2025 full-year figure at $3000.0, up 100.17% from the prior year.
- Tax Provisions for Q2 2025 stood at $3000.0, up from -$87000.0 in the prior quarter.
- Over the last five years, Tax Provisions for PGEN reached as high as $13000.0 in Q4 2021 and fell as low as -$1.7 million in Q2 2024.
- Historically, Tax Provisions has averaged -$152764.7 across 5 years, with a median of -$55000.0 in 2023.
- Across the five-year window, Tax Provisions plunged 4250.0% in 2023 and jumped 300.0% in 2024, its largest moves.
- Year by year, Tax Provisions stood at $13000.0 in 2021, then slumped by 38.46% to $8000.0 in 2022, then plunged by 4250.0% to -$332000.0 in 2023, then soared by 73.8% to -$87000.0 in 2024, then soared by 103.45% to $3000.0 in 2025.
- Per Business Quant data, the three most recent Tax Provisions figures were $3000.0 in Q2 2025, -$87000.0 in Q4 2024, and $12000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | -332,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -55,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | -50,000.00 |
| Jun 30, 2022 | -89,000.00 |
| Mar 31, 2022 | -58,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | -61,000.00 |
| Jun 30, 2021 | -60,000.00 |
| Mar 31, 2021 | -52,000.00 |
| Dec 31, 2020 | 48,000.00 |
| Sep 30, 2020 | -50,000.00 |
| Jun 30, 2020 | -120,000.00 |